Bringing the fundamentals into focus…
Back to Collegium Pharmaceutical, Inc.
How Collegium Pharmaceutical, Inc. stacks up
COLL · against 588 other Healthcare companies listed in US-listed
Valuation
92/ 100
Near the top of its peers.
Ranked #20 of 589 · scores higher than 96% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 90–100, including COLL · Click a bar to see the companies
Why valuation scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
- higher earnings for the price paid: stronger than 80% of peers. Earnings yield: 6.2% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 95% of peers. EBITDA yield: 21.8% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 99% of peers. Free cash flow yield: 42.5% vs peer median 0.0%
Metric by metric
Position: dot = COLL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | COLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 5.4% | -4.3% | 90% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 21.8% | -0.8% | 95% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 42.5% | -2.3% | 99% | 20% | |
| Book yieldHigher is better · 587 reported | 40.4% | 25.9% | 67% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around COLL| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 14 | 914M USD | 94 | 81 | |
| 18 | 5.8B USD | 93 | 64 | |
| 18 | 261M USD | 93 | 97 | |
| 20 | 301M USD | 92 | 67 | |
| 20 | 773M USD | 92 | 64 | |
| 20 | 11.6B USD | 92 | 57 | |
| 20 | 2.2B USD | 92 | 78 | |
| 20 | 177.5B USD | 92 | 71 | |
| 20 | 14.4B USD | 92 | 71 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score